The consistency of this protective effect is primarily due to the ability of C66 to suppress p300/CBP activation through long-term epigenetic modifications, which may affect the “metabolic memory” that may underlie diabetes itself (Karukurichi et al. 2010), (Villeneuve et al. 2011). Here, EP300 is linked to diabetes mellitus.